In patients with chronic renal failure, erythropoietin(EPO)-treated hemodialysis patients showed significantly increased amounts of TRPC5 mRNA in monocytes compared with EPO-free hemodialysis patients (92). This evidence concerns the gene EPO and chronic kidney disease.